
Shares of Bio-Techne TECH.O rise 4.54% to $67.57
The biotech firm reports Q2 revenue of $295.9 million, beating average of analysts' estimates of $290.2 million, as per data compiled by LSEG
Posts adjusted quarterly profit of 46 cents per share, above average estimate of 43 cents
*"We expect a recovery in the pharma end-market and biotech funding to support some growth in the coming quarters," Leerink Partners analysts said in a note
TECH slumped 18.35% in 2025